Excellent questions Gekkowolf.
No answers but just some insight in fundamental processes to consider.
Cancer, like many other diseases, is non-discriminatory. So, there may be a percentage of the population that can afford the services needed.
The extended time, as company announced, of results has an element of extended closure to one’s affairs. So, humans often need time to digest and accept information and deal with the continuity of loved one’s. Hard to put a price on health as studies show that I’ll-health and associated costs are ranked highly with personal bankruptcies especially in national without baseline public health care.
The notions on subsidies and associated departments/governments we wait and see. Of course, the durability of the studies extension of time combined with official FDA certification are two two of many indicators.
Avoiding the ‘Covid 19’ card.., sales of any product usually have a steady rising scale increasing over time and subject to effectiveness of product and customer or patient satisfaction.
Plenty of funds, plenty of behind the scenes ( imo), sales needed to transpire for a baseline of potential.
Luck to both patients and holders alike
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil receives Swiss regulatory approval
OSL
oncosil medical ltd
Add to My Watchlist
5.69%
!
$1.16

Ann: OncoSil receives Swiss regulatory approval, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 412 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9286 | 1.160 |
1 | 7500 | 1.080 |
2 | 19761 | 1.050 |
1 | 2500 | 1.030 |
1 | 550 | 1.020 |
Price($) | Vol. | No. |
---|---|---|
1.180 | 412 | 1 |
1.200 | 8677 | 1 |
1.245 | 2418 | 1 |
1.250 | 46027 | 1 |
1.300 | 1500 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online